SREBF2 and Alzheimer disease: The convergent evidence linking both genes to the SREBP2 pathway, combined with NBEAL1 proximity to cerebral small vessel disease loci19,20, implicates cerebrovascular cholesterol dysregulation as a mechanism contributing to AD pathogenesis (Figure 4h).